Notably, Chugai and LLY stocks spiked in April when the late-stage trial results of Orforglipron showed that it could reduce weight and blood sugar while ensuring safety on par with injectable ...

Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.